Eurofins
Eurofins Acquires Ascend Clinical
Eurofins said the deal helps support its efforts to expand within the transplant testing and renal care space.
CMS Clarifies Billing Article Revisions for Organ Transplant Rejection Testing
A statement from CMS clarifies that physician-ordered transplant rejection tests remain available when medically necessary.
Genomics England, Oxford Nanopore Partner for Project to Diagnose Unsolved Rare Disease Cases
As part of the project, Eurofins Genomics is contracted to perform whole-genome nanopore sequencing on 7,500 samples from the 100,000 Genomes Project.
US Supreme Court Declines to Hear CareDx Organ Transplant Patent Infringement Case
CareDx had petitioned the US Supreme Court to hear a patent infringement case brought against Natera and Eurofins Viracor.
MolDx Reimbursement Decision on Molecular Testing in Organ Transplants Causes Confusion, Concern
Premium
Transplant surgeons and patient advocates fear that the decision to reimburse only one test per patient visit will impede patient care and worsen healthcare disparities.
Jul 23, 2021
Feb 11, 2021
Eurofins Gets CE Mark for Coronavirus Antibody Test
Dec 15, 2020